We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Imaging Collaboration Spans Acquisition and Analysis

By LabMedica International staff writers
Posted on 12 Nov 2008
Definiens (Munich, Germany), an enterprise image intelligence company, and Hamamatsu Photonics (Hamamatsu City, Japan), a leading manufacturer of devices for the generation and measurement of infrared, visible, and ultraviolet light, recently signed a partnership agreement for the European market. More...


Under the terms of the sales and marketing agreement, Hamamatsu and Definiens will integrate Definiens image analysis platforms--Definiens Enterprise Image Intelligence Suite and Definiens XD including Definiens TissueMap--with Hamamatsu's NanoZoomer digital pathology system (NDP), a product range for virtual microscopy. The NanoZoomer scans tissue or cellular slides at remarkable speed and generates digital images with very high image quality. It creates digital slides that can be shared and viewed over a network. Definiens comprehensive image analysis platforms extract context-based data from any digital image in any dimension--be it two-dimensional (2D), 3D, or 4D.

Definiens image analysis platforms are a perfect match to Hamamatsu's NanoZoomer. The partnership will generate additional benefit for customers by integrating a sophisticated tissue slide scanner, capable of high throughput, sensitivity, and resolution with a unique image analysis technology that emulates human cognitive processes to automatically extract intelligence from digital images.

Life science and crop science research institutes as well as the pharmaceutical industry will benefit from a complete and fully integrated image analysis solution, which is closing the loop from high-end image acquisition to high-content and high-throughput image analysis.

"By partnering with Hamamatsu we can provide our joint customers with a complete image analysis solution, which enables them to automate image analysis processes, reduce costs, and make qualified decisions faster,” remarked Manfred Voglmaier, vice president Business Development Life Sciences at Definiens.

"Hamamatsu's NanoZoomer is a high-throughput slide scanning system with excellent image quality that--in combination with Definiens powerful image analysis software--enables histologists, pharmacologists, and pathologists to get more reliable and reproducible image analysis results,” added Dr. Erk Mennenga-Klopp, head of the medical solutions department at Hamamatsu, Germany.

Both companies will offer active marketing and sales support including training and consultancy. In addition, Definiens will provide application specialists and specific algorithm development for Hamamatsu's customer base.

Hamamatsu Photonics is a manufacturer of optronics (optoelectronic) components and systems. The company stresses the advancement of photonics through extensive research and development. The component and system products such as photosensors, cameras, and complex systems are widely used in different research fields such as communication, biomedical science, material science, pharmacology, medical science, and many others.

By automating image analysis on an enterprise level, Definiens supports life science organizations to analyze and interpret vast numbers of images accurately and consistently. Definiens improves the measurement of cell assays, the examination of tissue samples, and the interpretation of noninvasive imaging, enabling high-content screening, digital pathology, and translational medicine.

Definiens is a company focused on analyzing and interpreting images on every scale, from microscopic cell structures to satellite images. The Definiens Cognition Network Technology, developed by Nobel laureate Prof. Gerd Binnig and his team, is a sophisticated and context-based technology designed to fulfill the image analysis requirements of the life and earth sciences markets. The technology is modeled on the powerful human cognitive perception processes to extract intelligence from images.

Related Links:

Definiens
Hamamatsu Photonics



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.